The U.S. Court of Appeals for the Federal Circuit upheld a U.S. District Court decision that awarded $268 million in damages from Cochlear Ltd. (ASX:COH) to two competitors in a patent dispute. Yesterday’s ruling comes after several years of legal battles over the patents for hearing implants, and likely won’t be the end, as Cochlear is […]
FDA clears Cochlear piezoelectric hearing implant
The FDA has cleared a second-generation pioezoelectric bone-conduction hearing implant from Cochlear (ASX:COH), the company announced today. The Osia 2 system is an active osseointegrated, steady-state implant (OSI) that uses digital piezoelectric stimulation to bypass damaged areas of the natural hearing system to send sound vibrations directly to the inner ear. It is designed to […]
Judge raises patent award against Cochlear Ltd. to $268M
A federal judge in California has ordered Cochlear Ltd. (ASX:COH) to pay $268 million — double a jury’s previous award — to the Alfred E. Mann Foundation in a patent dispute. The foundation, named for one of the inventors of cochlear implant technology, sued Australia-based Cochlear in 2007, alleging infringement of a pair of patents covering […]
Cochlear donates $10m to Johns Hopkins for new hearing loss center, research
Cochlear Ltd. (ASX:COH) said today it donated $10 million to the Johns Hopkins Bloomberg School of Public Health to found the Cochlear Center for Hearing and Public Health, which it touted as the first academic institute looking to address hearing loss as a global health priority. The new center is slated to be led by […]
Sensorion, Cochlear collab to study combo therapies for patients with cochlear implants
Sensorion, a biotech working on therapies for inner ear diseases, said today that it inked a deal with Cochlear Ltd (ASX:COH) to study combination therapies for patients with cochlear implants. According to the deal, the companies will combine Sensorion’s SENS-401 compound with cochlear implants in preclinical studies starting next year. The drug-device therapies could be in clinical […]
FDA clears remote adjustments for Cochlear’s Nucleus implants
The FDA last week approved remote programming adjustments for Cochlear Ltd.‘s (ASX:COH) Nucleus cochlear implant, removing the need for a select group of users to make repeat visits for in-person programming sessions. The newly-cleared remote programming feature is indicated for patients with 6 months of experience with their cochlear implant sound processors and who are […]
Cochlear launches iOS-connectable Nucleus 7 cochlear implant
Cochlear Ltd. (ASX:COH) today launched its Nucleus 7 sound processor cochlear implant, touting it as the smallest and lightest behind-the-ear implant sound processor available. The Sydney-based company said that the newly launched Nucleus 7, which won FDA clearance last month, is the 1st cochlear implant designed to connect directly with Apple (NSDQ:AAPL) iOS devices, allowing individuals to stream […]
Zimmer Biomet prez, CEO Dvorak unexpectedly resigns | Personnel Moves, July 12, 2017
Zimmer Biomet (NYSE:ZBH) said late yesterday its prez and CEO David Dvorak has resigned from his position at the head of the company, effective immediately, to be replaced on an interim basis by senior VP and CFO Daniel Florin until a permanent successor is named. The Warsaw, Ind.-based company said it is retaining “a leading executive search […]
Cochlear shares jump on FDA nod for Nucleus 7 sound processor
Hearing implant maker Cochlear Ltd. (ASX:COH) has seen shares rise nearly 4% after the company won FDA approval for its Nucleus 7 sound processor, according to a Motley Fool Australia report. The newly cleared N7 processor is superior to its prior N6 version, and is compatible with Apple’s iOS, while its telecoil is optimized for loops, according […]
Cochlear dips on slumping China sales
(Reuters) — Cochlear Ltd. (ASX:COH), the world #1 hearing implants maker, yesterday posted record half-year profits on a robust U.S. sales, but a slump in China tender orders pushed its share price more than 3% lower when the market closed Down Under. Although Cochlear has come back from a damaging recall in 2011 to book strong results over the […]
Appeals court reverses Cochlear win in Advanced Bionics patent spat
A federal appeals court last week overturned a win for Cochlear Ltd. (ASX:COH) in its patent spat with Advanced Bionics over hearing implant technology, sending the case back to district court for reconsideration in light of a recent U.S. Supreme Court decision. The cochlear implant patents were licensed to Advanced Bionics by the Alfred E. Mann Foundation, named […]
